---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-350898"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2021-12-08T23:59:59+00:00"
generated_at: "2026-06-28T02:43:19.194504+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Corcept wins patent appeal, discloses DOJ subpoena on Korlym sales, extends tender offer to Dec 15

## Summary
- Federal Circuit affirmed PTAB decision upholding validity of '214 patent (expires 2037) against Teva challenge.
- Received HIPAA subpoena from NJ USAO regarding Korlym sales and HCP payments; investigating potential criminal/civil violations; Corcept not a defendant.
- Extended tender offer expiration to Dec 15, 2021; 8,282,336 shares tendered to date; condition of at least 3M shares tendered.

## SEC filing metadata
- accession: 0001193125-21-350898
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2021-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000119312521350898/0001193125-21-350898-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000119312521350898/d255329d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-350898
- JSON: https://secwatch.observer/filing/0001193125-21-350898.json
- Plain text: https://secwatch.observer/filing/0001193125-21-350898.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.